Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Non-Current Assets (2019 - 2021)

Greenwich LifeSciences filings provide 3 years of Non-Current Assets readings, the most recent being $13518.0 for Q3 2021.

  • Quarterly Non-Current Assets fell 21.09% to $13518.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $59490.0 through Sep 2021, changed N/A year-over-year, with the annual reading at $16227.0 for FY2020, 18.19% down from the prior year.
  • Non-Current Assets hit $13518.0 in Q3 2021 for Greenwich LifeSciences, down from $14421.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $19836.0 in Q4 2019 and bottomed at $13518.0 in Q3 2021.
  • Average Non-Current Assets over 3 years is $16076.0, with a median of $15775.5 recorded in 2020.
  • The largest annual shift saw Non-Current Assets fell 18.19% in 2020 before it fell 21.09% in 2021.
  • Greenwich LifeSciences' Non-Current Assets stood at $19836.0 in 2019, then decreased by 18.19% to $16227.0 in 2020, then decreased by 16.69% to $13518.0 in 2021.
  • Per Business Quant, the three most recent readings for GLSI's Non-Current Assets are $13518.0 (Q3 2021), $14421.0 (Q2 2021), and $15324.0 (Q1 2021).